Global health Qinhuangdao Biotechnology Co., Ltd., a subsidiary of China Qinhuangdao Kaiyi group, was founded in December 2019. It is a high-tech enterprise specializing in the research, development and production of raw and auxiliary materials for biopharmaceuticals. Its predecessor, global health Beijing Biotechnology Co., Ltd., established in 2011, is a high-tech enterprise in Zhongguancun, Beijing. Global health Qinhuangdao Biotechnology Co., Ltd. phase I has a total investment of 50 million yuan and a construction area of 7000 m2, including 2000 m2 of 100000 grade drug packaging material purification workshop, 1600 m2 of 10000 grade serum purification workshop, 500 m2 of quality inspection purification workshop and 200 m2 of independent experimental center. It mainly produces and operates two kinds of products, one is the raw material series of biological reagents with fetal bovine serum and newborn bovine serum as the upstream of the diagnosis industry, and the other is the drug packaging material series with culture medium bottle (PET) and culture dish as the main in the field of biopharmaceutical.Since its establishment, Globecom has been deeply rooted in the field of biopharmaceuticals after more than ten years of development. It is a high-quality supplier of upstream raw materials and consumables in the field of biopharmaceuticals. Customer service more than 1000, all over the diagnostic reagents, animal vaccine enterprise customers and universities, laboratories and other research institutions. With the concept of innovation, preciseness and professionalism, and the responsibility of developing domestic biological reagent industry, we are determined to work hard for the health of all mankind!